Lv54
870 积分 2024-05-13 加入
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
30天前
已完结
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
1个月前
已完结
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
1个月前
已完结
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma
1个月前
已完结
Real-world outcomes of tandem ASCT in newly diagnosed multiple myeloma patients with standard risk features: a single-center analysis
1个月前
已完结
RCHOP plus BTK Inhibitor Improves Clinical Outcomes in Double Expressor Diffuse Large B-Cell Lymphoma, Unlike RCHOP plus Lenalidomide
1个月前
已完结
Efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating non-Hodgkin lymphoma: A systematic review and meta-analysis of clinical trials
2个月前
已完结
Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged ≥60 Years
2个月前
已关闭
Long-term Follow-up of Zimberelimab in Relapsed or Refractory Classic Hodgkin Lymphoma: Insights from the Phase Ⅱ YH-S001-04 Clinical Trial
2个月前
已完结
Autologous Transplant (auto-HCT) Is Associated with Improved Clinical Outcomes Compared to CAR-T Therapy in Patients (pts) with Large B-Cell Lymphoma (LBCL) Achieving a Complete Remission
3个月前
已完结
皖公网安备34019202002308
